Secukinumab Rapidly Reduces Hidden Joint Inflammation in Psoriasis Patients

Secukinumab, an IL-17A inhibitor, significantly reduces subclinical enthesitis in patients with moderate-to-severe plaque psoriasis, according to a study published in the journal Skin. By targeting inflammation at the attachment points of tendons and ligaments before joint pain begins, this treatment may prevent irreversible structural damage associated with psoriatic arthritis (PsA), researchers from The Second Affiliated … Read more

Psoriasis & Arthritis: New Insights into Joint Inflammation & Early Detection

Psoriasis: From Skin Condition to Systemic Threat – New Insights into Joint Involvement Psoriasis isn’t solely a skin disease. In 20 to 30 percent of cases, the condition affects the joints, causing painful inflammation. Researchers in Germany have discovered a key mechanism explaining how the disease progresses to this arthritic form, as detailed in Nature … Read more

Low BSA Psoriasis: High Disease Burden Possible

Psoriasis Beyond the Surface: Unveiling the True Burden and Future Treatment Trends As a medical journalist specializing in dermatology, I’ve closely followed the evolving understanding of psoriasis and its impact. Recent research illuminates a critical point: the severity of the disease isn’t always reflected by the visible skin involvement. Let’s delve into these findings and … Read more

Dealing with Difficult or Unique Psoriasis Cases, with Douglas DiRuggiero, DMSc, MHS, PA-C

Decoding the Future: Emerging Trends in Psoriasis Management As a healthcare journalist specializing in dermatology, I’ve been following the evolution of psoriasis treatments for years. The recent insights shared by experts like Dr. Douglas DiRuggiero at the 2025 New Wave Dermatology Conference offer a compelling glimpse into the future. Let’s dive into the key trends … Read more

Bariatric Surgery Linked With Psoriasis Improvement

Bariatric Surgery and Psoriasis: A Promising Link and Future Trends For individuals grappling with both obesity and psoriasis, the journey to wellness can feel incredibly challenging. However, recent research is offering a glimmer of hope, revealing a significant connection between metabolic and bariatric surgery (MBS) and improved psoriasis outcomes. Let’s delve into the findings and … Read more

Increased risk of allergies and intellectual disability observed in children with early antibiotic exposure: Study

Early Antibiotics and Childhood Health: Unpacking Future Trends As a seasoned health journalist, I’ve been following the evolving understanding of early childhood health with keen interest. A recent study published in The Journal of Infectious Diseases has reignited a crucial conversation: the link between early exposure to antibiotics and the development of various chronic conditions … Read more

Effective Strategies for Treating Psoriasis: Essential Expert Advice and Updated Treatment Insights

Unraveling the Future of Psoriasis Treatment: Insights from Top Experts With pioneering research led by experts such as Dr. Álvaro González Cantero, we’re entering a transformative era in treating psoriasis. This chronic condition affects two to three percent of Spain’s population and is on the cusp of receiving more curative therapies. Dr. González Cantero, from … Read more

Non-Pharmacologic Therapies in PsO and PsA: 5 Things to Know

The Future of Managing Psoriasis and Psoriatic Arthritis: More Than Just Medication Managing psoriasis and Psoriatic Arthritis (PsA) encompasses more than just pharmacological interventions. As research progresses, the medical community is increasingly recognizing the potential of nonpharmacologic therapies. Here, we delve into the future trends that could revolutionize holistic management for individuals affected by these … Read more

Biologics Linked to Lower Infection Risk in Older Adults With Psoriatic Disease

Unlocking the Future of Psoriatic Disease Treatment in Older Adults A groundbreaking study published in JAMA Dermatology has shed light on the potential of biologics targeting interleukin (IL)-12, IL-23, or IL-17 in reducing serious infections among older adults with psoriatic disease. This emerging evidence could significantly influence treatment practices and patient outcomes in the future. … Read more

Targeting SSAT enzyme offers new hope for psoriasis treatment

The Future of Psoriasis Treatment: A New Horizon Psoriasis, a chronic inflammatory skin disease affecting millions worldwide, is on the brink of a transformative treatment evolution. With recent insights from researchers at MedUni Vienna, the focus is shifting from traditional immunosuppressive therapies to novel, targeted approaches that could significantly reduce side effects and improve patient … Read more